Lucia Cortijo-Gonzalez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study.
Journal: Breast (Edinburgh, Scotland)
Published: March 24, 2026
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer.
Journal: Cancer research communications
Published: July 25, 2025
Vascular calcifications in early-breast radiotherapy planning-CT: Opportunistic detection and cardiovascular risk assessment.
Journal: Clinical and translational radiation oncology
Published: June 28, 2025
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.
Journal: Breast (Edinburgh, Scotland)
Published: June 03, 2025
ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 22, 2025
Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer.
Journal: Radiation oncology (London, England)
Published: October 23, 2024
Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas.
Journal: Cancers
Published: May 29, 2024
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 30, 2023
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 04, 2023
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Journal: EClinicalMedicine
Published: February 27, 2023
Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study).
Journal: Cancer treatment and research communications
Published: January 17, 2023
Targeting carcinoma-associated mesothelial cells with antibody-drug conjugates in ovarian carcinomatosis.
Journal: The Journal of pathology
Published: December 22, 2022
Last Updated: 09/26/2026